Literature DB >> 14561755

A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.

Lisa A Kuttner-Kondo1, Megan P Dybvig, Lynne M Mitchell, Nasima Muqim, John P Atkinson, M Edward Medof, Dennis E Hourcade.   

Abstract

The cleavage of C3 by the C3 convertases (C3bBb and C4b2a) determines whether complement activation proceeds. Dissociation (decay acceleration) of these central enzymes by the regulators decay-accelerating factor (DAF), complement receptor 1 (CR1), factor H, and C4-binding protein (C4BP) controls their function. In a previous investigation, we obtained evidence implicating the alpha4/5 region of the type A domain of Bb (especially Tyr338) in decay acceleration of C3bBb and proposed this site as a potential interaction point with DAF and long homologous repeat A of CR1. Because portions of only two DAF complement control protein domains (CCPs), CCP2 and CCP3, are necessary to mediate its decay of the CP C3 convertase (as opposed to portions of at least three CCPs in all other cases, e.g. CCPs 1-3 of CR1), DAF/C4b2a provides the simplest structural model for this reaction. Therefore, we examined the importance of the C2 alpha4/5 site on decay acceleration of C4b2a. Functional C4b2a complexes made with the C2 Y327A mutant, the C2 homolog to factor B Y338A, were highly resistant to DAF, C4BP, and long homologous repeat A of CR1, whereas C2 substitutions in two nearby residues (N324A and L328A) resulted in partial resistance. Our new findings indicate that the alpha4/5 region of C2a is critical to decay acceleration mediated by DAF, C4BP, and CR1 and suggest that decay acceleration of C4b2a and C3bBb requires interaction of the convertase alpha4/5 region with a CCP2/CCP3 site of DAF or structurally homologous sites of CR1 and C4BP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561755     DOI: 10.1074/jbc.M304620200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins.

Authors:  Hemendra Singh Panwar; Hina Ojha; Payel Ghosh; Sagar H Barage; Sunil Raut; Arvind Sahu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

2.  Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.

Authors:  Kwok-Min Hui; George L Orriss; Tilman Schirmer; Bergljót Magnadóttir; Jürg A Schifferli; Jameel M Inal
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

3.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  Dissection of functional sites in herpesvirus saimiri complement control protein homolog.

Authors:  Malik Johid Reza; Ashish Kamble; Muzammil Ahmad; Musti V Krishnasastry; Arvind Sahu
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

5.  Sequence diversity of the Trypanosoma cruzi complement regulatory protein family.

Authors:  M Beucher; K A Norris
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

6.  Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.

Authors:  Akhilesh K Singh; Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

7.  C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex.

Authors:  Pallop Karnchanaphanurach; Rossen Mirchev; Ionita Ghiran; John M Asara; Brigitte Papahadjopoulos-Sternberg; Anne Nicholson-Weller; David E Golan
Journal:  J Clin Invest       Date:  2009-03-02       Impact factor: 14.808

8.  Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.

Authors:  Federico Forneris; Jin Wu; Xiaoguang Xue; Daniel Ricklin; Zhuoer Lin; Georgia Sfyroera; Apostolia Tzekou; Elena Volokhina; Joke Cm Granneman; Richard Hauhart; Paula Bertram; M Kathryn Liszewski; John P Atkinson; John D Lambris; Piet Gros
Journal:  EMBO J       Date:  2016-03-24       Impact factor: 11.598

Review 9.  Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion.

Authors:  Elise S Hovingh; Bryan van den Broek; Ilse Jongerius
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

10.  Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics.

Authors:  Anna Felberg; Aleksandra Urban; Anna Borowska; Grzegorz Stasiłojć; Michał Taszner; Andrzej Hellmann; Anna Maria Blom; Marcin Okrój
Journal:  Cancer Immunol Immunother       Date:  2019-02-06       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.